Stock viewBusiness Today
Divis, Gland, Sai Life Sciences shares hit 52-week highs
Positive0
GreyOak summary
Divis Laboratories, Gland Pharma, and Sai Life Sciences shares reached 52-week highs. Divis reported a 64% rise in Q2 net profit to Rs 1127 crore. Gland Pharma saw a 58.2% profit increase to Rs 291 crore. Sai Life Sciences shares also rallied, buoyed by the sector's positive earnings momentum.
What it affects
- Gland PharmaGLANDPositive 0
Stock surged to 52-week high after Q2 results.Rolling sentiment Positive +64
- Divi's LaboratoriesDIVISLABPositive 0
Shares hit 52-week high on strong Q2 earnings.Rolling sentiment Positive +80
- Sai Life SciencesSAILIFEPositive 0
Shares rallied to 52-week high on sector momentum.Rolling sentiment Positive +64
Source
Read the original at Business TodayMore Gland Pharma news
- Five Stocks To Buy Today, November 11: Gland Pharma, Sansera Engineering, Union Bank, And MoreNDTV Profit · Stock view ·
- Gland Pharma shares rally 8% to hit 4-year-high post strong Q2Moneycontrol · Results ·
- Gland Pharma shares jump 7% to 52-week highCNBC-TV18 · Stock view ·
- Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%Business Standard · Stock view ·
- Gland Pharma shares jump 4% as Q2 profit jumps 58%Economic Times · Results ·